This content is from:Premium This Surging Biotech Company Has Attracted a Web of Hedge Fund Managers Several big-name hedge funds are enjoying gains from Axovant Sciences, whose parent company was founded by a former hedge fund manager. ByStephen Taub June 08, 2018
This content is from:365亚博 The Morning Brief: Barclays Cuts Price Target on Greenlight Short Athenahealth ByStephen Taub November 28, 2016
This content is from:Premium Citadel Posts Smallest Gain in Years in Tough Year for Multistrats The firm’s Wellington fund rebounded sharply from a sizable loss in the first quarter. January 13, 2017
This content is from:Premium Citadel Continues Its Reversal of Fortune with October Gains Ken Griffin's flagship fund is now in the middle of the pack of multistrategy funds after a rough start to the year. ByStephen Taub November 07, 2016
This content is from:Premium The Hottest Sector Has Attracted the Most Short Interest Longs and shorts are having a tug-o-war over red-hot biotechnology stocks. ByStephen Taub September 11, 2017
This content is from:Premium Dan Gold Explains QVT’s October Losses in Memorable Letter In his latest letter to investors, the manager expresses disappointment over his performance, explains why he thinks his fund did worse than it should have and offers a colorful caveat. ByStephen Taub October 30, 2014
